Pravastatin Sodium

CHEMBL690 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
446.5 g/mol
LogP
Phase
4

A sodium salt form of pravastatin with the same therapeutic properties. A statin medication used to lower elevated cholesterol and triglyceride levels in the blood, reducing the risk of heart attacks, strokes, and the need for heart procedures.

Molekularmasse

446,5000 g/mol

TPSA

127,00 Ų

Therapeutische Bereiche

Wirkmechanismus

Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Competitive inhibitor of HMG-CoA reductase.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+]

InChI

InChI=1S/C23H36O7.Na/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28;/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28);/q;+1/p-1/t13-,14-,16+,17+,18+,19-,20-,22-;/m0./s1

Molecular Formula

C23H35NaO7

HBD / HBA

3 / 7

Rotierbare Bindungen

11

Schwere Atome

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A sodium salt form of pravastatin with the same therapeutic properties. A statin medication used to lower elevated cholesterol and triglyceride levels in the blood, reducing the risk of heart attacks, strokes, and the need for heart procedures.

Competitive inhibitor of HMG-CoA reductase.

Yes, Pravastatin Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL690. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 16759173. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.